HR 1189
National Plan for Epilepsy Act
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The National Plan for Epilepsy Act establishes a national strategy to combat epilepsy in the United States. It directs the Department of Health and Human Services to create and maintain a National Plan for Epilepsy, focusing on prevention, diagnosis, treatment, and cure. The bill also creates an Advisory Council to advise the Secretary on epilepsy-related issues and requires annual reports to Congress assessing progress and recommending future actions. This plan aims to improve outcomes and reduce the burden of epilepsy on individuals and families.
Key provisions
- Establishes a National Plan for Epilepsy led by the Department of Health and Human Services.
- Creates an Advisory Council on Epilepsy Research, Care, and Services to advise the Secretary.
- Requires annual reports to Congress assessing the nation’s progress on epilepsy.
- Mandates the sharing of epilepsy-related data among federal agencies.
- Directs the Secretary to coordinate research and services across all federal agencies.
- Calls for the development of safe and effective treatments for epilepsy.
- Requires an assessment of the nation’s progress in preparing for and responding to the burden of epilepsy.
- Sets a sunset date of December 31, 2035, for the provisions of the act.
Who is affected
- Individuals with epilepsy and their caregivers
- Healthcare providers
- Federal agencies (including NIH, CMS, CDC, FDA, HRSA, DoD, and VA)
- Researchers
- The general public
Notable changes
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Becca [D-VT-At Large] Balint
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
119th CONGRESS — 1st Session
H. R. 1189
IN THE HOUSE OF REPRESENTATIVES
A BILL
To establish a national plan to coordinate research on epilepsy, and for other purposes.
This Act may be cited as the National Plan for Epilepsy Act
.
Congress finds as follows:
Epilepsy is a brain disorder that causes recurring and unprovoked seizures and affects people of all ages, affecting nearly 3,000,000 adults and 456,000 children in the United States.
Epilepsy and seizures can develop in any person at any age. One in 26 people will develop a form of epilepsy in their lifetime, with people from all demographic groups and walks of life being impacted.
In approximately half of all cases of epilepsy, the underlying cause of the disease is unknown.
Epilepsy is a spectrum disease comprised of many diagnoses and an ever-growing number of rare epilepsies. There are many different types of seizures and varying levels of seizure control.
Over 30 percent of people with epilepsy live with uncontrolled seizures.
Individuals with epilepsy have a 3-times higher risk of early death than the general population and that risk is even higher for individuals with uncontrolled seizures.
Thirty-two percent of adults with epilepsy are unable to work.
Fifty-three percent of individuals with uncontrolled seizures live in households earning less than $25,000 per year.
Health care costs associated with epilepsy and seizures exceed $54,000,000,000 per year in the United States.
Part B of title III of the Public Health Service Act (42 U.S.C. 243 et seq.) is amended by adding at the end the following:
The Secretary shall carry out a national project, to be known as the National Plan for Epilepsy
(referred to in this section as the National Plan
), to prevent, diagnose, treat, and cure epilepsy.
establish, maintain, and periodically update an integrated national plan to prevent, diagnose, treat, and cure epilepsy;
provide information, including an estimate of the level of Federal investment in preventing, diagnosing, treating, and curing epilepsy;
encourage the development of safe and effective treatments, strategies, and other approaches to prevent, diagnose, treat, and cure epilepsy or to enhance functioning and improve quality of life for individuals with epilepsy and their caregivers;
improve the—
early diagnosis of epilepsy; and
coordination of the care and treatment of individuals living with epilepsy;
review the impact of epilepsy on the physical, mental, and social health of individuals living with epilepsy and their caregivers;
solicit public comments and consider consensus recommendations from collaborations in the epilepsy community;
carry out an annual assessment on progress of the activities described in this subsection;
coordinate with international bodies, to the degree possible, to integrate and inform the global mission to prevent, diagnose, treat, and cure epilepsy; and
carry out other such activities as the Secretary determines appropriate.
Not later than 2 years after the date of enactment of the
National Plan for Epilepsy Act
, and annually thereafter, the Secretary shall carry out an assessment of the Nation’s progress in preparing for and responding to the escalating burden of epilepsy. Such assessment shall include—recommendations for priority actions;
a description of the steps that have been, or should be, taken to implement such recommendations; and
such other items as the Secretary determines appropriate.
Advisory Council) to advise the Secretary on epilepsy-related issues.
4 individuals, each of whom is living with a different type of epilepsy;
2 family caregivers for individuals with epilepsy;
2 licensed or accredited health care providers supported by a relevant professional medical society, including at least 1 epileptologist or neurologist;
2 biomedical researchers with epilepsy-related expertise in basic, translational, or clinical population science or drug development science; and
3 representatives from 3 separate nonprofit organizations directly connected with epilepsy that have demonstrated experience in epilepsy research or epilepsy patient care and other services.
Not later than 2 years after the date of enactment of the
National Plan for Epilepsy Act
, and every 2 years thereafter, the Advisory Council shall convene a meeting of Federal and non-Federal organizations to discuss epilepsy research.All meetings of the Advisory Council shall be open to the public.
Not later than 18 months after the date of enactment of the
National Plan for Epilepsy Act
, and every 2 years thereafter, the Advisory Council shall provide to the Secretary and Congress a report containing—an evaluation of all federally funded efforts in preventing, diagnosing, treating, and curing epilepsy, and the outcomes of such efforts;
recommendations for priority actions to better coordinate, expand, and better support Federal programs in order to better support people with epilepsy, epilepsy research, and data collection; and
recommendations to—
provide effective, timely, and responsive diagnosis treatment and care to improve health outcomes and quality of life;
foster research and innovation leading to more effective treatments and potential cures for epilepsy;
strengthen data and information systems including better surveillance of epilepsy;
increase public awareness about epilepsy and reduce stigma and discrimination;
increase access to expert and specialized care for people with epilepsy;
eliminate access to care disparities experienced by individuals with epilepsy;
prevent sudden unexpected death in epilepsy and other epilepsy-related mortalities;
reduce the financial impact of epilepsy on families living with epilepsy;
prevent epilepsy and promote healthy behaviors; and
an evaluation of the implementation of the National Plan, and its outcomes.
recommendations for—
priority actions based on the most recent assessment submitted by the Secretary under subsection (b) and the recommendations contained in the most recent report of the Advisory Council under subsection (c)(4);
priority actions to improve all federally funded efforts in epilepsy research, prevention, diagnosis, treatment, clinical care, and institutional-, home-, and community-based programs; and
implementation steps to address priority actions described in subparagraphs (A) and (B); and
a description of the progress made in carrying out the National Plan.
Agencies both within the Department of Health and Human Services and outside of such Department that have data relating to epilepsy shall share such data with the Secretary as necessary to enable the Secretary to complete the reports described in subsection (d).
This section shall cease to be effective on December 31, 2035.